This page lists all known medications that could potentially lead to 'Plasmacytoma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2017; 15: e538-e548. Pauleit D, Zimmermann A, ...

Correct diagnosis of solitary plasmacytoma as the cause of gastrointestinal blood loss and anemia is important because localized plasmacytoma are radiosensitive. The treatment of choice for a ...

Extramedullary plasmacytoma and solitary plasmacytoma represent rare manifestations of plasma cell dyscrasias, where abnormal plasma cells accumulate as a single localised lesion. In the case of ...

Phase II study of PRO95780 plus rituximab in patients with relapsed follicular non-Hodgkin's lymphoma (NHL). Background: Solitary plasmacytoma is a rare plasma-cell neoplasm. We wanted to assess the ...

The incidence of multiple myeloma, solitary plasmacytoma, and extramedullary plasmacytoma has increased between 2003 and 2016. The rate of mortality for multiple myeloma decreased over that same ...

Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer We provide an overview on ...

Please provide your email address to receive an email when new articles are posted on . A 37-year-old woman originally presented in 2003 with the gradual onset of paresthesias and weakness of the ...

Background A 70-year-old white male diagnosed with IgA lambda multiple myeloma, who had been treated with two cycles of melphalan and prednisone, was evaluated for persistent anemia. He had required ...

A 70-year-old white male, who had been diagnosed with IgA lambda multiple myeloma 4 months previously, was referred to the Mayo Clinic for further evaluation of anemia. The patient had required over ...